| (S)-nicotine | decreases expression | ISO | RGD:619567 | 6480464 | Nicotine results in decreased expression of BGLAP | CTD | PMID:19436947 |
| (S)-nicotine | multiple interactions | ISO | RGD:619567 | 6480464 | Tubocurarine inhibits the reaction [Nicotine results in increased expression of BGLAP] | CTD | PMID:19436947 |
| (S)-nicotine | increases expression | ISO | RGD:619567 | 6480464 | Nicotine results in increased expression of BGLAP | CTD | PMID:19436947 |
| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:619567 | 6480464 | VDR gene polymorphism affects the reaction [[Ethinyl Estradiol co-treated with Levonorgestrel] affects the expression of BGLAP protein] | CTD | PMID:12521655 |
| 17alpha-ethynylestradiol | affects expression | EXP | | 6480464 | Ethinyl Estradiol affects the expression of BGLAP protein | CTD | PMID:11861784 PMID:15261309 |
| 17alpha-ethynylestradiol | affects expression | EXP | | 6480464 | Ethinyl Estradiol affects the expression of BGLAP protein | CTD | PMID:15261309 PMID:11861784 |
| 17beta-estradiol | multiple interactions | ISO | RGD:619567 | 6480464 | [Estradiol co-treated with ESR1 protein] results in increased expression of BGLAP mRNA; more ... | CTD | PMID:19347870 |
| 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of BGLAP protein | CTD | PMID:15917159 PMID:15979666 |
| 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of BGLAP mRNA | CTD | PMID:16964405 |
| 17beta-estradiol | multiple interactions | ISO | RGD:619567 | 6480464 | fulvestrant inhibits the reaction [Estradiol results in increased expression of BGLAP mRNA] | CTD | PMID:17689939 |
| 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of BGLAP protein | CTD | PMID:15979666 PMID:15917159 |
| 17beta-estradiol | increases expression | ISO | RGD:619567 | 6480464 | Estradiol results in increased expression of BGLAP mRNA | CTD | PMID:17689939 |
| 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one | increases expression | ISO | RGD:619567 | 6480464 | Metribolone results in increased expression of BGLAP mRNA | CTD | PMID:19759027 |
| 17beta-hydroxy-5alpha-androstan-3-one | increases expression | ISO | RGD:1621635 | 6480464 | Dihydrotestosterone results in increased expression of BGLAP mRNA | CTD | PMID:17898587 |
| 17beta-hydroxy-5alpha-androstan-3-one | increases expression | ISO | RGD:1621634 | 6480464 | Dihydrotestosterone results in increased expression of BGLAP mRNA | CTD | PMID:17898587 |
| 17beta-hydroxy-5alpha-androstan-3-one | increases expression | ISO | | 6480464 | Dihydrotestosterone results in increased expression of BGLAP mRNA | CTD | PMID:17898587 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1621635 | 6480464 | AHR protein affects the reaction [Tetrachlorodibenzodioxin results in decreased expression of BGLAP mRNA] | CTD | PMID:19264158 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1621634 | 6480464 | tributyltin promotes the reaction [Tetrachlorodibenzodioxin results in decreased expression of BGLAP mRNA] | CTD | PMID:22749964 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1621634 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of BGLAP mRNA | CTD | PMID:19264158 PMID:22749964 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1621634 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of BGLAP mRNA | CTD | PMID:19264158 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1621634 | 6480464 | AHR protein affects the reaction [Tetrachlorodibenzodioxin results in decreased expression of BGLAP mRNA] | CTD | PMID:19264158 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of BGLAP mRNA | CTD | PMID:19201780 PMID:19264158 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of BGLAP mRNA | CTD | PMID:19264158 PMID:19201780 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of BGLAP mRNA | CTD | PMID:19264158 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of BGLAP | CTD | PMID:19367694 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | | 6480464 | AHR protein affects the reaction [Tetrachlorodibenzodioxin results in decreased expression of BGLAP mRNA] | CTD | PMID:19264158 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1621634 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of BGLAP | CTD | PMID:19367694 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1621635 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of BGLAP mRNA | CTD | PMID:19264158 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1621635 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of BGLAP | CTD | PMID:19367694 |
| 2,4,6-trinitrobenzenesulfonic acid | decreases expression | ISO | RGD:1621635 | 6480464 | Trinitrobenzenesulfonic Acid results in decreased expression of BGLAP-RS1 mRNA | CTD | PMID:17982090 |
| 2-amino-2-deoxy-D-glucopyranose | increases expression | ISO | RGD:619567 | 6480464 | Glucosamine analog results in increased expression of BGLAP mRNA | CTD | PMID:20458730 |
| 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine | increases expression | EXP | | 6480464 | Puromycin Aminonucleoside results in increased expression of BGLAP protein | CTD | PMID:9154658 |
| 3-aminobenzamide | increases expression | ISO | RGD:619567 | 6480464 | 3-aminobenzamide results in increased expression of BGLAP mRNA | CTD | PMID:15670817 |
| 5-azacytidine | decreases expression | EXP | | 6480464 | Azacitidine results in decreased expression of BGLAP protein | CTD | PMID:18037191 |
| 5-fluorouracil | increases expression | EXP | | 6480464 | Fluorouracil results in increased expression of BGLAP mRNA | CTD | PMID:16888818 |
| 9-cis-retinoic acid | decreases expression | ISO | RGD:1621635 | 6480464 | alitretinoin results in decreased expression of BGLAP mRNA | CTD | PMID:16392701 |
| 9-cis-retinoic acid | decreases expression | ISO | | 6480464 | alitretinoin results in decreased expression of BGLAP mRNA | CTD | PMID:16392701 |
| 9-cis-retinoic acid | decreases expression | ISO | RGD:619567 | 6480464 | alitretinoin results in decreased expression of BGLAP mRNA | CTD | PMID:12898515 |
| 9-cis-retinoic acid | multiple interactions | ISO | RGD:619567 | 6480464 | alitretinoin promotes the reaction [Calcitriol results in increased expression of BGLAP mRNA]; more ... | CTD | PMID:12898515 |
| 9-cis-retinoic acid | decreases expression | ISO | RGD:1621634 | 6480464 | alitretinoin results in decreased expression of BGLAP mRNA | CTD | PMID:16392701 |
| aldehydo-D-glucosamine | increases expression | ISO | RGD:619567 | 6480464 | Glucosamine analog results in increased expression of BGLAP mRNA | CTD | PMID:20458730 |
| all-trans-retinoic acid | multiple interactions | ISO | | 6480464 | [Tretinoin co-treated with Cholecalciferol] results in increased expression of BGLAP | CTD | PMID:17170073 |
| all-trans-retinoic acid | increases expression | ISO | RGD:1621634 | 6480464 | Tretinoin results in increased expression of BGLAP mRNA | CTD | PMID:16889531 |
| all-trans-retinoic acid | decreases expression | ISO | RGD:1621634 | 6480464 | Tretinoin results in decreased expression of BGLAP mRNA | CTD | PMID:16350840 PMID:16392701 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:1621634 | 6480464 | [Tretinoin co-treated with Cholecalciferol] results in increased expression of BGLAP | CTD | PMID:17170073 |
| all-trans-retinoic acid | decreases expression | ISO | RGD:1621635 | 6480464 | Tretinoin results in decreased expression of BGLAP mRNA | CTD | PMID:16350840 PMID:16392701 |
| all-trans-retinoic acid | decreases expression | ISO | | 6480464 | Tretinoin results in decreased expression of BGLAP mRNA | CTD | PMID:16392701 PMID:16350840 |
| all-trans-retinoic acid | increases expression | ISO | RGD:1621635 | 6480464 | Tretinoin results in increased expression of BGLAP mRNA | CTD | PMID:16889531 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:1621635 | 6480464 | [Tretinoin co-treated with Cholecalciferol] results in increased expression of BGLAP | CTD | PMID:17170073 |
| all-trans-retinoic acid | decreases expression | ISO | RGD:1621635 | 6480464 | Tretinoin results in decreased expression of BGLAP mRNA | CTD | PMID:16392701 PMID:16350840 |
| all-trans-retinoic acid | increases expression | ISO | | 6480464 | Tretinoin results in increased expression of BGLAP mRNA | CTD | PMID:16889531 |
| all-trans-retinoic acid | decreases expression | ISO | | 6480464 | Tretinoin results in decreased expression of BGLAP mRNA | CTD | PMID:16350840 PMID:16392701 |
| aluminium atom | multiple interactions | EXP | | 6480464 | Aluminum inhibits the reaction [Calcitriol results in increased secretion of BGLAP protein]; more ... | CTD | PMID:9626627 |
| aluminium atom | decreases secretion | EXP | | 6480464 | Aluminum results in decreased secretion of BGLAP protein | CTD | PMID:9626627 |
| aluminium oxide | increases expression | ISO | RGD:619567 | 6480464 | Aluminum Oxide results in increased expression of BGLAP mRNA | CTD | PMID:19464052 |
| aluminium trichloride | decreases expression | EXP | | 6480464 | aluminum chloride results in decreased expression of BGLAP protein | CTD | PMID:23065425 |
| aluminium(0) | multiple interactions | EXP | | 6480464 | Aluminum inhibits the reaction [Calcitriol results in increased secretion of BGLAP protein]; more ... | CTD | PMID:9626627 |
| aluminium(0) | decreases secretion | EXP | | 6480464 | Aluminum results in decreased secretion of BGLAP protein | CTD | PMID:9626627 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of BGLAP mRNA | CTD | PMID:16483693 |
| beta-D-glucosamine | increases expression | ISO | RGD:619567 | 6480464 | Glucosamine analog results in increased expression of BGLAP mRNA | CTD | PMID:20458730 |
| boron atom | increases expression | ISO | RGD:619567 | 6480464 | Boron results in increased expression of BGLAP mRNA | CTD | PMID:21625915 |
| cadmium atom | increases expression | ISO | RGD:619567 | 6480464 | Cadmium results in increased expression of BGLAP mRNA | CTD | PMID:20570719 |
| cadmium atom | decreases expression | ISO | RGD:619567 | 6480464 | Cadmium results in decreased expression of BGLAP mRNA | CTD | PMID:20570719 |
| calciol | multiple interactions | ISO | | 6480464 | [Tretinoin co-treated with Cholecalciferol] results in increased expression of BGLAP | CTD | PMID:17170073 |
| calciol | multiple interactions | ISO | RGD:1621634 | 6480464 | [Tretinoin co-treated with Cholecalciferol] results in increased expression of BGLAP | CTD | PMID:17170073 |
| calciol | multiple interactions | ISO | RGD:1621635 | 6480464 | [Tretinoin co-treated with Cholecalciferol] results in increased expression of BGLAP | CTD | PMID:17170073 |
| calciol | increases secretion | ISO | RGD:619567 | 6480464 | Cholecalciferol results in increased secretion of BGLAP protein | CTD | PMID:17996099 |
| calciol | multiple interactions | ISO | RGD:619567 | 6480464 | [Cholecalciferol co-treated with beta-glycerophosphoric acid co-treated with Ascorbic Acid] results in increased expression of BGLAP protein | CTD | PMID:17692823 |
| calciol | increases expression | EXP | | 6480464 | Cholecalciferol results in increased expression of BGLAP mRNA | CTD | PMID:19759027 |
| calcitriol | increases expression | ISO | RGD:1621634 | 6480464 | Calcitriol results in increased expression of BGLAP mRNA | CTD | PMID:16889531 |
| calcitriol | multiple interactions | EXP | | 6480464 | Aluminum inhibits the reaction [Calcitriol results in increased secretion of BGLAP protein]; more ... | CTD | PMID:9626627 |
| calcitriol | increases expression | ISO | RGD:619567 | 6480464 | Calcitriol results in increased expression of BGLAP mRNA | CTD | PMID:10470102 more ... |
| calcitriol | increases expression | ISO | RGD:619567 | 6480464 | Calcitriol results in increased expression of BGLAP mRNA | CTD | PMID:17293108 more ... |
| calcitriol | increases expression | ISO | RGD:619567 | 6480464 | Calcitriol results in increased expression of BGLAP mRNA | CTD | PMID:17293108 more ... |
| calcitriol | increases expression | ISO | RGD:619567 | 6480464 | Calcitriol results in increased expression of BGLAP mRNA | CTD | PMID:10470102 more ... |
| calcitriol | increases expression | ISO | RGD:619567 | 6480464 | Calcitriol results in increased expression of BGLAP mRNA | CTD | PMID:17293108 more ... |
| calcitriol | increases expression | ISO | RGD:1621635 | 6480464 | Calcitriol results in increased expression of BGLAP mRNA | CTD | PMID:16889531 |
| calcitriol | decreases expression | ISO | RGD:1621635 | 6480464 | Calcitriol results in decreased expression of BGLAP mRNA | CTD | PMID:17293108 |
| calcitriol | increases expression | ISO | RGD:619567 | 6480464 | Calcitriol results in increased expression of BGLAP mRNA | CTD | PMID:10470102 more ... |
| calcitriol | increases expression | EXP | | 6480464 | Calcitriol results in increased expression of BGLAP mRNA | CTD | PMID:16813520 |
| calcitriol | increases expression | ISO | | 6480464 | Calcitriol results in increased expression of BGLAP mRNA | CTD | PMID:16889531 |
| calcitriol | decreases expression | ISO | | 6480464 | Calcitriol results in decreased expression of BGLAP mRNA | CTD | PMID:17293108 |
| calcitriol | increases secretion | ISO | RGD:619567 | 6480464 | Calcitriol results in increased secretion of BGLAP protein | CTD | PMID:12898515 |
| calcitriol | increases expression | ISO | RGD:619567 | 6480464 | Calcitriol results in increased expression of BGLAP mRNA | CTD | PMID:16267019 more ... |
| calcitriol | multiple interactions | ISO | RGD:619567 | 6480464 | Calcitriol promotes the reaction [VDR protein binds to BGLAP enhancer] | CTD | PMID:17293108 |
| calcitriol | multiple interactions | ISO | RGD:619567 | 6480464 | [Calcitriol co-treated with resveratrol] results in increased expression of BGLAP mRNA | CTD | PMID:16267019 |
| calcitriol | multiple interactions | ISO | RGD:619567 | 6480464 | alitretinoin promotes the reaction [Calcitriol results in increased expression of BGLAP mRNA]; more ... | CTD | PMID:12898515 |
| calcitriol | decreases expression | ISO | RGD:1621634 | 6480464 | Calcitriol results in decreased expression of BGLAP mRNA | CTD | PMID:17293108 |
| calcium carbonate | decreases expression | ISO | RGD:619567 | 6480464 | Calcium Carbonate results in decreased expression of BGLAP protein | CTD | PMID:2027271 |
| choline | multiple interactions | ISO | RGD:1621635 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of BGLAP-RS1 mRNA | CTD | PMID:20938992 |
| copper atom | multiple interactions | ISO | RGD:619567 | 6480464 | [Ascorbic Acid co-treated with Copper] affects the cleavage of BGLAP-RS1 protein | CTD | PMID:11396734 |
| copper atom | affects binding | ISO | RGD:619567 | 6480464 | BGLAP-RS1 protein binds to Copper | CTD | PMID:11396734 |
| copper(0) | multiple interactions | ISO | RGD:619567 | 6480464 | [Ascorbic Acid co-treated with Copper] affects the cleavage of BGLAP-RS1 protein | CTD | PMID:11396734 |
| copper(0) | affects binding | ISO | RGD:619567 | 6480464 | BGLAP-RS1 protein binds to Copper | CTD | PMID:11396734 |
| copper(2+) sulfate | decreases expression | ISO | RGD:619567 | 6480464 | Copper Sulfate results in decreased expression of BGLAP mRNA | CTD | PMID:19549813 |
| cycloheximide | multiple interactions | ISO | RGD:1621634 | 6480464 | Cycloheximide inhibits the reaction [[Genistein co-treated with Zinc] results in increased expression of BGLAP mRNA]; more ... | CTD | PMID:17203194 |
| cycloheximide | multiple interactions | ISO | RGD:1621635 | 6480464 | Cycloheximide inhibits the reaction [[Genistein co-treated with Zinc] results in increased expression of BGLAP mRNA]; more ... | CTD | PMID:17203194 |
| cycloheximide | multiple interactions | ISO | | 6480464 | Cycloheximide inhibits the reaction [[Genistein co-treated with Zinc] results in increased expression of BGLAP mRNA]; more ... | CTD | PMID:17203194 |
| daidzein | multiple interactions | ISO | RGD:619567 | 6480464 | [daidzein co-treated with ESR2 protein] results in increased expression of BGLAP mRNA; more ... | CTD | PMID:19347870 |
| dexamethasone | multiple interactions | ISO | RGD:619567 | 6480464 | [Ascorbic Acid co-treated with Dexamethasone] results in increased expression of BGLAP mRNA | CTD | PMID:12510807 |
| dexamethasone | multiple interactions | EXP | | 6480464 | [Simvastatin co-treated with Dexamethasone] results in increased expression of BGLAP | CTD | PMID:19216230 |
| elemental boron | increases expression | ISO | RGD:619567 | 6480464 | Boron results in increased expression of BGLAP mRNA | CTD | PMID:21625915 |
| folic acid | multiple interactions | ISO | RGD:1621635 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of BGLAP-RS1 mRNA | CTD | PMID:20938992 |
| fulvestrant | multiple interactions | ISO | RGD:619567 | 6480464 | fulvestrant inhibits the reaction [Estradiol results in increased expression of BGLAP mRNA]; more ... | CTD | PMID:17689939 |
| genistein | multiple interactions | ISO | RGD:1621635 | 6480464 | Cycloheximide inhibits the reaction [[Genistein co-treated with Zinc Sulfate] results in increased expression of BGLAP mRNA]; more ... | CTD | PMID:17203194 |
| genistein | multiple interactions | ISO | | 6480464 | Cycloheximide inhibits the reaction [[Genistein co-treated with Zinc] results in increased expression of BGLAP mRNA]; more ... | CTD | PMID:17203194 |
| genistein | multiple interactions | ISO | RGD:619567 | 6480464 | [Genistein co-treated with ESR1 protein] results in increased expression of BGLAP mRNA; more ... | CTD | PMID:19347870 |
| genistein | multiple interactions | ISO | RGD:1621634 | 6480464 | Cycloheximide inhibits the reaction [[Genistein co-treated with Zinc] results in increased expression of BGLAP mRNA]; more ... | CTD | PMID:17203194 |
| glycerol 2-phosphate | multiple interactions | ISO | RGD:619567 | 6480464 | [Cholecalciferol co-treated with beta-glycerophosphoric acid co-treated with Ascorbic Acid] results in increased expression of BGLAP protein | CTD | PMID:17692823 |
| glycyrrhetinate | multiple interactions | ISO | RGD:1621634 | 6480464 | 18alpha-glycyrrhetinic acid inhibits the reaction [BMP2 protein results in increased expression of BGLAP mRNA]; more ... | CTD | PMID:21910061 |
| glycyrrhetinic acid | multiple interactions | ISO | RGD:1621634 | 6480464 | 18alpha-glycyrrhetinic acid inhibits the reaction [BMP2 protein results in increased expression of BGLAP mRNA]; more ... | CTD | PMID:21910061 |
| hydrogen chloride | increases expression | ISO | RGD:619567 | 6480464 | Hydrochloric Acid results in increased expression of BGLAP | CTD | PMID:17183249 |
| ifosfamide | decreases expression | ISO | RGD:619567 | 6480464 | Ifosfamide results in decreased expression of BGLAP protein | CTD | PMID:1525342 |
| isonicotinamide | increases expression | EXP | | 6480464 | isonicotinamide results in increased expression of BGLAP mRNA | CTD | PMID:16813520 |
| isonicotinamide | increases expression | ISO | RGD:619567 | 6480464 | isonicotinamide results in increased expression of BGLAP mRNA | CTD | PMID:21745208 |
| L-ascorbic acid | affects binding | ISO | RGD:619567 | 6480464 | BGLAP-RS1 protein binds to Ascorbic Acid | CTD | PMID:11396734 |
| L-ascorbic acid | multiple interactions | ISO | RGD:619567 | 6480464 | [Cholecalciferol co-treated with beta-glycerophosphoric acid co-treated with Ascorbic Acid] results in increased expression of BGLAP protein | CTD | PMID:17692823 |
| L-ascorbic acid | multiple interactions | ISO | RGD:619567 | 6480464 | [Ascorbic Acid co-treated with Dexamethasone] results in increased expression of BGLAP mRNA | CTD | PMID:12510807 |
| L-ascorbic acid | multiple interactions | ISO | RGD:619567 | 6480464 | [Ascorbic Acid co-treated with Copper] affects the cleavage of BGLAP-RS1 protein | CTD | PMID:11396734 |
| L-methionine | multiple interactions | ISO | RGD:1621635 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of BGLAP-RS1 mRNA | CTD | PMID:20938992 |
| levonorgestrel | multiple interactions | ISO | RGD:619567 | 6480464 | VDR gene polymorphism affects the reaction [[Ethinyl Estradiol co-treated with Levonorgestrel] affects the expression of BGLAP protein] | CTD | PMID:12521655 |
| magnesium atom | increases expression | ISO | RGD:619567 | 6480464 | Magnesium results in increased expression of BGLAP protein | CTD | PMID:10397942 |
| melatonin | increases expression | ISO | RGD:619567 | 6480464 | Melatonin results in increased expression of BGLAP mRNA | CTD | PMID:20738756 |
| menadione | decreases expression | ISO | RGD:619567 | 6480464 | Vitamin K 3 results in decreased expression of BGLAP mRNA | CTD | PMID:19675304 |
| menaquinone | multiple interactions | ISO | RGD:619567 | 6480464 | Vitamin K 2 inhibits the reaction [IL1B protein results in decreased expression of BGLAP protein modified form] | CTD | PMID:20460758 |
| menaquinone | decreases expression | ISO | RGD:619567 | 6480464 | Vitamin K 2 results in decreased expression of BGLAP mRNA | CTD | PMID:19675304 |
| montelukast | increases expression | ISO | RGD:1621635 | 6480464 | montelukast results in increased expression of BGLAP mRNA | CTD | PMID:19544365 |
| montelukast | increases expression | ISO | | 6480464 | montelukast results in increased expression of BGLAP mRNA | CTD | PMID:19544365 |
| montelukast | increases expression | ISO | RGD:1621634 | 6480464 | montelukast results in increased expression of BGLAP mRNA | CTD | PMID:19544365 |
| nitric acid | increases expression | EXP | | 6480464 | Nitric Acid results in increased expression of BGLAP protein | CTD | PMID:16436523 |
| norethisterone | increases secretion | ISO | RGD:619567 | 6480464 | Norethindrone results in increased secretion of BGLAP protein | CTD | PMID:8053399 |
| poly(ethylene) | decreases expression | ISO | RGD:619567 | 6480464 | Polyethylene results in decreased expression of BGLAP protein | CTD | PMID:10225790 |
| quercetin | decreases expression | EXP | | 6480464 | Quercetin results in decreased expression of BGLAP mRNA | CTD | PMID:14757127 |
| quercetin | decreases expression | ISO | RGD:619567 | 6480464 | Quercetin results in decreased expression of BGLAP mRNA | CTD | PMID:21632981 |
| raloxifene | decreases expression | ISO | RGD:619567 | 6480464 | Raloxifene results in decreased expression of BGLAP protein | CTD | PMID:17823083 |
| resveratrol | multiple interactions | ISO | RGD:619567 | 6480464 | [Calcitriol co-treated with resveratrol] results in increased expression of BGLAP mRNA | CTD | PMID:16267019 |
| resveratrol | increases expression | ISO | RGD:619567 | 6480464 | resveratrol results in increased expression of BGLAP mRNA | CTD | PMID:16267019 more ... |
| resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of BGLAP protein | CTD | PMID:21715682 |
| resveratrol | increases expression | ISO | RGD:619567 | 6480464 | resveratrol results in increased expression of BGLAP mRNA | CTD | PMID:16267019 more ... |
| resveratrol | increases expression | ISO | RGD:619567 | 6480464 | resveratrol results in increased expression of BGLAP mRNA | CTD | PMID:16267019 PMID:17689939 |
| resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of BGLAP mRNA | CTD | PMID:16813520 PMID:16964405 |
| resveratrol | increases expression | ISO | RGD:619567 | 6480464 | resveratrol results in increased expression of BGLAP mRNA | CTD | PMID:17689939 PMID:16267019 |
| resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of BGLAP mRNA | CTD | PMID:16964405 PMID:16813520 |
| resveratrol | multiple interactions | ISO | RGD:619567 | 6480464 | fulvestrant inhibits the reaction [resveratrol results in increased expression of BGLAP mRNA]; more ... | CTD | PMID:17689939 |
| rosiglitazone | affects expression | ISO | RGD:1621635 | 6480464 | rosiglitazone affects the expression of BGLAP protein | CTD | PMID:18948404 |
| rosiglitazone | affects expression | ISO | | 6480464 | rosiglitazone affects the expression of BGLAP protein | CTD | PMID:18948404 |
| rosiglitazone | decreases expression | ISO | | 6480464 | rosiglitazone results in decreased expression of BGLAP mRNA | CTD | PMID:12021203 |
| rosiglitazone | affects expression | ISO | RGD:1621634 | 6480464 | rosiglitazone affects the expression of BGLAP protein | CTD | PMID:18948404 |
| rosiglitazone | decreases expression | ISO | RGD:1621634 | 6480464 | rosiglitazone results in decreased expression of BGLAP mRNA | CTD | PMID:12021203 |
| rosiglitazone | decreases expression | ISO | RGD:1621635 | 6480464 | rosiglitazone results in decreased expression of BGLAP mRNA | CTD | PMID:12021203 |
| simvastatin | multiple interactions | ISO | RGD:1621635 | 6480464 | DKK1 inhibits the reaction [Simvastatin results in increased expression of BGLAP mRNA]; more ... | CTD | PMID:22058016 |
| simvastatin | increases expression | ISO | RGD:1621634 | 6480464 | Simvastatin results in increased expression of BGLAP protein | CTD | PMID:12914771 more ... |
| simvastatin | increases expression | ISO | RGD:1621634 | 6480464 | Simvastatin results in increased expression of BGLAP | CTD | PMID:20564244 |
| simvastatin | increases expression | ISO | | 6480464 | Simvastatin results in increased expression of BGLAP mRNA | CTD | PMID:12914771 more ... |
| simvastatin | increases expression | ISO | | 6480464 | Simvastatin results in increased expression of BGLAP protein | CTD | PMID:12914771 more ... |
| simvastatin | increases expression | ISO | RGD:619567 | 6480464 | Simvastatin results in increased expression of BGLAP mRNA | CTD | PMID:15953866 more ... |
| simvastatin | increases expression | ISO | RGD:1621635 | 6480464 | Simvastatin results in increased expression of BGLAP mRNA | CTD | PMID:12914771 more ... |
| simvastatin | increases expression | ISO | RGD:1621635 | 6480464 | Simvastatin results in increased expression of BGLAP protein | CTD | PMID:12914771 more ... |
| simvastatin | increases expression | ISO | RGD:1621635 | 6480464 | Simvastatin results in increased expression of BGLAP protein | CTD | PMID:22058016 more ... |
| simvastatin | increases expression | ISO | RGD:1621635 | 6480464 | Simvastatin results in increased expression of BGLAP mRNA | CTD | PMID:14601315 more ... |
| simvastatin | increases expression | ISO | RGD:619567 | 6480464 | Simvastatin results in increased expression of BGLAP mRNA | CTD | PMID:21431270 more ... |
| simvastatin | increases expression | ISO | RGD:1621635 | 6480464 | Simvastatin results in increased expression of BGLAP mRNA | CTD | PMID:22058016 more ... |
| simvastatin | increases expression | ISO | RGD:619567 | 6480464 | Simvastatin results in increased expression of BGLAP mRNA | CTD | PMID:15953866 more ... |
| simvastatin | increases expression | ISO | RGD:1621635 | 6480464 | Simvastatin results in increased expression of BGLAP protein | CTD | PMID:12914771 more ... |
| simvastatin | increases expression | ISO | RGD:1621635 | 6480464 | Simvastatin results in increased expression of BGLAP protein | CTD | PMID:14601315 more ... |
| simvastatin | increases expression | ISO | RGD:1621635 | 6480464 | Simvastatin results in increased expression of BGLAP mRNA | CTD | PMID:14973129 more ... |
| simvastatin | increases expression | ISO | RGD:619567 | 6480464 | Simvastatin results in increased expression of BGLAP mRNA | CTD | PMID:17252541 more ... |
| simvastatin | increases expression | ISO | | 6480464 | Simvastatin results in increased expression of BGLAP mRNA | CTD | PMID:22058016 more ... |
| simvastatin | increases expression | ISO | | 6480464 | Simvastatin results in increased expression of BGLAP protein | CTD | PMID:22058016 more ... |
| simvastatin | increases expression | ISO | RGD:619567 | 6480464 | Simvastatin results in increased expression of BGLAP mRNA | CTD | PMID:17252541 more ... |
| simvastatin | increases expression | EXP | | 6480464 | Simvastatin results in increased expression of BGLAP protein | CTD | PMID:19292885 |
| simvastatin | multiple interactions | EXP | | 6480464 | [Simvastatin co-treated with Dexamethasone] results in increased expression of BGLAP | CTD | PMID:19216230 |
| simvastatin | increases expression | ISO | | 6480464 | Simvastatin results in increased expression of BGLAP protein | CTD | PMID:14601315 more ... |
| simvastatin | increases expression | ISO | | 6480464 | Simvastatin results in increased expression of BGLAP mRNA | CTD | PMID:14973129 more ... |
| simvastatin | increases expression | ISO | | 6480464 | Simvastatin results in increased expression of BGLAP | CTD | PMID:20564244 |
| simvastatin | multiple interactions | ISO | | 6480464 | CTNNB1 mutant form inhibits the reaction [Simvastatin results in increased expression of BGLAP protein]; more ... | CTD | PMID:22058016 |
| simvastatin | increases secretion | ISO | RGD:619567 | 6480464 | Simvastatin results in increased secretion of BGLAP protein | CTD | PMID:20381859 |
| simvastatin | increases expression | ISO | RGD:619567 | 6480464 | Simvastatin results in increased expression of BGLAP mRNA | CTD | PMID:21431270 more ... |
| simvastatin | increases expression | ISO | RGD:619567 | 6480464 | Simvastatin results in increased expression of BGLAP | CTD | PMID:20381859 |
| simvastatin | increases expression | ISO | RGD:1621634 | 6480464 | Simvastatin results in increased expression of BGLAP mRNA | CTD | PMID:12914771 more ... |
| simvastatin | multiple interactions | ISO | RGD:1621634 | 6480464 | CTNNB1 mutant form inhibits the reaction [Simvastatin results in increased expression of BGLAP protein]; more ... | CTD | PMID:22058016 |
| simvastatin | increases expression | ISO | RGD:1621635 | 6480464 | Simvastatin results in increased expression of BGLAP protein | CTD | PMID:22058016 more ... |
| simvastatin | increases expression | ISO | RGD:1621635 | 6480464 | Simvastatin results in increased expression of BGLAP | CTD | PMID:20564244 |
| simvastatin | increases expression | ISO | RGD:1621635 | 6480464 | Simvastatin results in increased expression of BGLAP mRNA | CTD | PMID:22058016 more ... |
| tamoxifen | multiple interactions | ISO | RGD:619567 | 6480464 | [Tamoxifen co-treated with ESR1 protein] results in increased expression of BGLAP mRNA | CTD | PMID:19347870 |
| tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of BGLAP protein | CTD | PMID:12631673 |
| titanium atom | increases expression | EXP | | 6480464 | Titanium results in increased expression of BGLAP mRNA | CTD | PMID:15914587 |
| trans-resveratrol | multiple interactions | ISO | RGD:619567 | 6480464 | [Calcitriol co-treated with resveratrol] results in increased expression of BGLAP mRNA | CTD | PMID:16267019 |
| trans-resveratrol | increases expression | ISO | RGD:619567 | 6480464 | resveratrol results in increased expression of BGLAP mRNA | CTD | PMID:16267019 more ... |
| trans-resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of BGLAP protein | CTD | PMID:21715682 |
| trans-resveratrol | increases expression | ISO | RGD:619567 | 6480464 | resveratrol results in increased expression of BGLAP mRNA | CTD | PMID:16267019 more ... |
| trans-resveratrol | increases expression | ISO | RGD:619567 | 6480464 | resveratrol results in increased expression of BGLAP mRNA | CTD | PMID:16267019 PMID:17689939 |
| trans-resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of BGLAP mRNA | CTD | PMID:16813520 PMID:16964405 |
| trans-resveratrol | increases expression | ISO | RGD:619567 | 6480464 | resveratrol results in increased expression of BGLAP mRNA | CTD | PMID:17689939 PMID:16267019 |
| trans-resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of BGLAP mRNA | CTD | PMID:16964405 PMID:16813520 |
| trans-resveratrol | multiple interactions | ISO | RGD:619567 | 6480464 | fulvestrant inhibits the reaction [resveratrol results in increased expression of BGLAP mRNA]; more ... | CTD | PMID:17689939 |
| tributylstannane | multiple interactions | ISO | RGD:1621634 | 6480464 | tributyltin promotes the reaction [Tetrachlorodibenzodioxin results in decreased expression of BGLAP mRNA] | CTD | PMID:22749964 |
| tributylstannane | increases expression | ISO | RGD:1621634 | 6480464 | tributyltin results in increased expression of BGLAP mRNA | CTD | PMID:22749964 |
| troglitazone | decreases expression | EXP | | 6480464 | troglitazone results in decreased expression of BGLAP mRNA | CTD | PMID:16813520 |
| tubocurarine | multiple interactions | ISO | RGD:619567 | 6480464 | Tubocurarine inhibits the reaction [Nicotine results in increased expression of BGLAP] | CTD | PMID:19436947 |
| uranium atom | increases expression | EXP | | 6480464 | Uranium results in increased expression of BGLAP protein | CTD | PMID:16436523 |
| zinc atom | decreases expression | ISO | RGD:1621634 | 6480464 | Zinc results in decreased expression of BGLAP protein | CTD | PMID:22228435 |
| zinc atom | decreases expression | EXP | | 6480464 | Zinc deficiency results in decreased expression of BGLAP protein; more ... | CTD | PMID:21893222 |
| zinc atom | decreases expression | ISO | | 6480464 | Zinc results in decreased expression of BGLAP protein | CTD | PMID:22228435 |
| zinc atom | multiple interactions | ISO | RGD:1621635 | 6480464 | Cycloheximide inhibits the reaction [[Genistein co-treated with Zinc] results in increased expression of BGLAP mRNA] | CTD | PMID:17203194 |
| zinc atom | multiple interactions | ISO | | 6480464 | Cycloheximide inhibits the reaction [[Genistein co-treated with Zinc] results in increased expression of BGLAP mRNA] | CTD | PMID:17203194 |
| zinc atom | multiple interactions | ISO | RGD:1621634 | 6480464 | Cycloheximide inhibits the reaction [[Genistein co-treated with Zinc] results in increased expression of BGLAP mRNA] | CTD | PMID:17203194 |
| zinc dichloride | multiple interactions | ISO | RGD:1621634 | 6480464 | [zinc chloride co-treated with N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine] results in increased expression of BGLAP mRNA; more ... | CTD | PMID:19913120 |
| zinc dichloride | multiple interactions | ISO | | 6480464 | [zinc chloride co-treated with N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine] results in increased expression of BGLAP mRNA; more ... | CTD | PMID:19913120 |
| zinc sulfate | multiple interactions | ISO | | 6480464 | Cycloheximide inhibits the reaction [[Genistein co-treated with Zinc Sulfate] results in increased expression of BGLAP mRNA] | CTD | PMID:17203194 |
| zinc sulfate | multiple interactions | ISO | RGD:1621634 | 6480464 | [Genistein co-treated with Zinc Sulfate] results in increased expression of BGLAP mRNA; more ... | CTD | PMID:17203194 |
| zinc sulfate | multiple interactions | ISO | RGD:1621635 | 6480464 | Cycloheximide inhibits the reaction [[Genistein co-treated with Zinc Sulfate] results in increased expression of BGLAP mRNA] | CTD | PMID:17203194 |
| zinc(0) | multiple interactions | ISO | RGD:1621634 | 6480464 | Cycloheximide inhibits the reaction [[Genistein co-treated with Zinc] results in increased expression of BGLAP mRNA] | CTD | PMID:17203194 |
| zinc(0) | decreases expression | ISO | | 6480464 | Zinc results in decreased expression of BGLAP protein | CTD | PMID:22228435 |
| zinc(0) | decreases expression | EXP | | 6480464 | Zinc deficiency results in decreased expression of BGLAP protein; more ... | CTD | PMID:21893222 |
| zinc(0) | multiple interactions | ISO | RGD:1621635 | 6480464 | Cycloheximide inhibits the reaction [[Genistein co-treated with Zinc] results in increased expression of BGLAP mRNA] | CTD | PMID:17203194 |
| zinc(0) | decreases expression | ISO | RGD:1621634 | 6480464 | Zinc results in decreased expression of BGLAP protein | CTD | PMID:22228435 |
| zinc(0) | multiple interactions | ISO | | 6480464 | Cycloheximide inhibits the reaction [[Genistein co-treated with Zinc] results in increased expression of BGLAP mRNA] | CTD | PMID:17203194 |
| zoledronic acid | increases expression | ISO | RGD:619567 | 6480464 | zoledronic acid results in increased expression of BGLAP mRNA | CTD | PMID:14751568 |